Literature DB >> 28504609

Age and sex differences in serum adiponectin and its association with lipoprotein fractions.

Yoshiharu Tomono1,2, Chika Hiraishi1,2, Hiroshi Yoshida1,2,3.   

Abstract

Objective The correlation of adiponectin with cholesterol concentration of fractionated lipoproteins has not been well investigated. Methods This study included 174 subjects (79 men and 95 women) without diabetes. The medical record data were investigated retrospectively. The study subjects with adiponectin <8.3, > 8.3 but less 13.9, and ≥ 13.9 were classified into tertile groups: Groups A ( n = 59), B ( n = 58) and C ( n = 57), respectively. Results In women, age and HDL-C were higher in Group C than in Groups A and B, but BMI, TG, IDL-C and VLDL-C were lower in Group C than in Groups A and B. In men, BMI was lower in Group C than in Groups A and B, and HDL-C was higher in Group C than in Groups A and B. In multiple stepwise regression analysis, BMI and HDL-C were significantly correlated with adiponectin in whole, male and female subjects, but TG-rich lipoprotein cholesterol concentrations were not independently correlated. Conclusions HDL-C and BMI were independently correlated with adiponectin in non-diabetic men and women. These results suggest that high adiponectin may play a role in the increased HDL-C concentrations, implicated in the reduction of cardiovascular disease risk, in non-diabetic subjects.

Entities:  

Keywords:  Adiponectin; BMI; HDL-C; age; lipoprotein fraction; sex difference

Mesh:

Substances:

Year:  2017        PMID: 28504609     DOI: 10.1177/0004563217699233

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN: 0004-5632            Impact factor:   2.057


  8 in total

1.  Key Clinical Factors Predicting Adipokine and Oxidative Stress Marker Concentrations among Normal, Overweight and Obese Pregnant Women Using Artificial Neural Networks.

Authors:  Mario Solis-Paredes; Guadalupe Estrada-Gutierrez; Otilia Perichart-Perera; Araceli Montoya-Estrada; Mario Guzmán-Huerta; Héctor Borboa-Olivares; Eyerahi Bravo-Flores; Arturo Cardona-Pérez; Veronica Zaga-Clavellina; Ethel Garcia-Latorre; Gabriela Gonzalez-Perez; José Alfredo Hernández-Pérez; Claudine Irles
Journal:  Int J Mol Sci       Date:  2017-12-28       Impact factor: 5.923

Review 2.  Beneficial Effects of Adiponectin on Glucose and Lipid Metabolism and Atherosclerotic Progression: Mechanisms and Perspectives.

Authors:  Hidekatsu Yanai; Hiroshi Yoshida
Journal:  Int J Mol Sci       Date:  2019-03-08       Impact factor: 5.923

Review 3.  Adipocytokines: Are they the Theory of Everything?

Authors:  Pierre S Maximus; Zeina Al Achkar; Pousette F Hamid; Syeda S Hasnain; Cesar A Peralta
Journal:  Cytokine       Date:  2020-06-16       Impact factor: 3.861

Review 4.  Interaction between adipocytes and high-density lipoprotein:new insights into the mechanism of obesity-induced dyslipidemia and atherosclerosis.

Authors:  Tianhua Zhang; Jin Chen; Xiaoyu Tang; Qin Luo; Danyan Xu; Bilian Yu
Journal:  Lipids Health Dis       Date:  2019-12-16       Impact factor: 3.876

5.  Interactive association between dietary fat and sex on CDH13 cg02263260 methylation.

Authors:  Bei-Hao Shiu; Wen-Yu Lu; Disline Manli Tantoh; Ming-Chih Chou; Oswald Ndi Nfor; Chi-Chou Huang; Yung-Po Liaw
Journal:  BMC Med Genomics       Date:  2021-01-06       Impact factor: 3.063

6.  Galectin-3/adiponectin as a new biological indicator for assessing the risk of type 2 diabetes: a cross-sectional study in a community population.

Authors:  Diaozhu Lin; Xiaosi Hong; Kan Sun; Xiaoyun Zhang; Hong Lian; Jiahuan Wang; Na Mao; Xiuwei Zhang; Meng Ren; Li Yan; Feng Li; Lili You
Journal:  Aging (Albany NY)       Date:  2021-06-07       Impact factor: 5.682

7.  Links Between Adiponectin and Dementia: From Risk Factors to Pathophysiology.

Authors:  RuiJuan Chen; Yi Shu; Yi Zeng
Journal:  Front Aging Neurosci       Date:  2020-01-08       Impact factor: 5.750

Review 8.  The Role of Anti-Inflammatory Adipokines in Cardiometabolic Disorders: Moving beyond Adiponectin.

Authors:  Han Na Jung; Chang Hee Jung
Journal:  Int J Mol Sci       Date:  2021-12-16       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.